RESUMEN
Several lines say that a number of natural products, mostly plant based, have been claimed to cure male sexual dysfunction. One of such botanicals is Carpolobia alba G. Don which is used in Cameroon to treat erectile dysfunction and related male sexual debilities. However, the traditional claim has not been scientifically tested. Thirty adult male rats (five groups of six animals) were orally treated daily with distilled water, sildenafil citrate (positive control), 75, 150, 300 mg/kg of C. alba G. Don roots aqueous extract. The erection and ejaculation properties were recorded on the first, seventh and fourteenth day of treatment by following copulation settings: number of erections (NE), mount frequency (MF), intromission frequency (IF), ejaculation frequency (EF), mount latency (ML), intromission latency (IL), ejaculation latency (EL), average interval of copulation (AIC) and post-ejaculatory interval (PEI). The extract resulted in an improvement of copulation parameters through significant reduction (p < .001) of PEI, ML and IL and significant increase (p < .001) in the NE, MF, IF, EF, EL and AIC. These results indicate a pro-erectile and pro-ejaculatory potential of aqueous root extract of this plant in male rats.
Asunto(s)
Eyaculación/efectos de los fármacos , Erección Peniana/efectos de los fármacos , Extractos Vegetales/farmacología , Raíces de Plantas , Polygalaceae , Conducta Sexual Animal/efectos de los fármacos , Animales , Copulación/efectos de los fármacos , Masculino , RatasRESUMEN
The effect of ethanolic extract of Fagara tessmannii, wide medicinal plants used on reproductive function in South Cameroon, was investigated in male rats. Twenty male sexually experienced rats (four groups) were orally treated with vehicle, 0.01, 0.1, 1 g kg(-1) BW per day of F. tessmannii (equivalent to 16.67 g, 33.33 g, 50 g, 66.66 g kg(-1) dry raw material) for 14 days, the upper limit dose without any clinical sign of toxicity was 2 g kg(-1). Fagara tessmannii extract negatively affected weight of accessory organs and significantly affected body weight gain at dose 1 g kg(-1) (P < 0.05) in treated rats. The weight of epididymis and seminal vesicle significantly decreased at low doses (0.01 g kg(-1)) while the prostate weight decreased at all doses (P < 0.05). The transit of spermatozoa in cauda epididymidis significantly increased at lower dose of 0.01 g kg(-1) (P < 0.05). In addition, F. tessmannii extract affected neither daily sperm production (DSP) and DSP per g nor sperm count in vas deferens and epididymis. The length of stages IX-I of the seminiferous tubule and serum testosterone level increased dose-dependently following 14 days of treatment (P < 0.05). The results suggest that F. tessmannii, 14 days after treatment, may improve spermatogenesis, testosterone level and sperm transit in cauda epididymidis but negatively impair reproductive organ activities.
Asunto(s)
Genitales Masculinos/efectos de los fármacos , Extractos Vegetales/farmacología , Rutaceae/química , Testículo/efectos de los fármacos , Testículo/fisiología , Testosterona/sangre , Animales , Epidídimo/anatomía & histología , Etanol , Genitales Masculinos/anatomía & histología , Masculino , Tamaño de los Órganos/efectos de los fármacos , Ratas , Vesículas Seminales/anatomía & histología , Transporte Espermático/efectos de los fármacos , Espermatogénesis/efectos de los fármacos , Aumento de Peso/efectos de los fármacosRESUMEN
Turraeanthus africanus (Meliacaeae) is known to possess a broad spectrum of pharmacological, medicinal and therapeutic properties. However, no extensive safety studies have been conducted on these extracts to date. The aim of this study was to evaluate toxicity of the aqueous extract of Turraeanthus africanus (Meliacaeae) after oral and intraperitoneal administration in mice. The acute toxicity was evaluated after single daily administration of the aqueous extract orally at doses of 0, 5, 10, 15, 20, 30 g kg(-1) or by the intraperitoneal route at doses of 0, 3, 6, 9, 12 g kg(-1) of raw material. The subacute toxicity was evaluated only by the intraperitoneal route for 6 weeks at doses of 1.5, 3, 6 g kg(-1) of raw material. Oral doses up to 30 g kg(-1) of the aqueous extract of Turraeanthus africanus (TA) did not produce mortality or significant changes in the general behaviour and gross appearance of internal organs of rats. However, the intraperitoneal administration of the aqueous extract of Turraeanthus africanus caused dose-dependent lethal effects. The acute intraperitoneal toxicity (LD(50)) of TA extract in mice was 7.2 g kg(-1). In subacute toxicity in mice, after the intraperitoneal administration of TA extract for 6 consecutive weeks, the feed consumption was significantly affected at the dose 3 g kg(-1) with P < 0.05 and at the dose 6 g kg(-1) with P < 0.001 and consequently had significant effect with P < 0.05 in body weight of animals. Level of triglyceride of treated animals lowered at dose 1.5 g kg(-1) with P < 0.001 and at dose 3 g kg(-1) and 6 g kg(-1) with P < 0.05. Total cholesterol level of treated animals lowered at dose 1.5 g kg(-1) with P < 0.005 and at dose 3 and 6 g kg(-1) with P < 0.001. HDL cholesterol level of treated animals lowered up to dose 6 g kg(-1) with P < 0.05 while levels of LDL cholesterol, serum and tissue creatinine of treated animals lowered at dose 3 g kg(-1) and dose 6 g kg(-1) with P < 0.05. Serum protein level of treated animal enhanced at dose 1.5 g kg(-1) and at dose 6 g kg(-1) with P < 0.05 while tissue creatinine level of treated animal enhanced with P < 0.001. The histology of liver, kidney and lung of the treated mice indicated morphological change of these organs (data not shown). No significant difference was observed during treatment concerning the haematological parameters. The results suggest that the plant is not toxic through the oral route in mice and that parenteral administration should be avoided.